Formidable Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
MCI
Formidable Asset Management's REGN Position: Q3 2026 in Review
Formidable Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 24% in Q3 2026, selling an estimated $151K and leaving 647 shares worth $491K. The position accounts for 0.07% of the portfolio, ranked #242.
Formidable Asset Management first reported a position in REGN in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.32M in Q4 2022. 607 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Formidable Asset Management held 647 shares of Regeneron Pharmaceuticals worth $491K as of Q3 2026.
- Formidable Asset Management sold 200 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $151K.
- Regeneron Pharmaceuticals made up 0.07% of Formidable Asset Management's portfolio in Q3 2026, its #242 holding.
- Formidable Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 21 quarters since.
- Formidable Asset Management's Regeneron Pharmaceuticals position peaked at $1.32M in Q4 2022.
- 607 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Formidable Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.